Free Trial

Calumet Specialty Products Partners (NASDAQ:CLMT) Shares Up 3.7% - Time to Buy?

Calumet Specialty Products Partners logo with Energy background
Remove Ads

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report)'s share price was up 3.7% on Wednesday . The stock traded as high as $12.60 and last traded at $12.69. Approximately 73,200 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 700,350 shares. The stock had previously closed at $12.23.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. Wells Fargo & Company reduced their price objective on Calumet Specialty Products Partners from $29.00 to $28.00 and set an "overweight" rating on the stock in a research note on Wednesday, March 5th. UBS Group raised Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and decreased their price target for the stock from $15.00 to $12.00 in a research note on Monday, March 17th. HC Wainwright reissued a "buy" rating and set a $33.00 price objective on shares of Calumet Specialty Products Partners in a research note on Monday, March 3rd. Finally, TD Cowen downgraded shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and decreased their target price for the stock from $26.00 to $16.00 in a research note on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $20.80.

Check Out Our Latest Research Report on CLMT

Calumet Specialty Products Partners Stock Down 2.2 %

The company has a market cap of $1.13 billion, a P/E ratio of -4.77 and a beta of 1.88. The business has a fifty day moving average of $14.72 and a 200 day moving average of $18.47.

Remove Ads

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last announced its earnings results on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share for the quarter, beating analysts' consensus estimates of ($1.06) by $0.59. The company had revenue of $949.50 million for the quarter, compared to the consensus estimate of $921.76 million. During the same period in the previous year, the firm posted ($0.59) EPS. The company's revenue for the quarter was down 2.8% on a year-over-year basis. On average, sell-side analysts anticipate that Calumet Specialty Products Partners, L.P. will post -3.02 EPS for the current fiscal year.

Insiders Place Their Bets

In other Calumet Specialty Products Partners news, Director Stephen P. Mawer sold 3,655 shares of the firm's stock in a transaction that occurred on Monday, March 24th. The shares were sold at an average price of $12.88, for a total transaction of $47,076.40. Following the completion of the transaction, the director now owns 287,307 shares of the company's stock, valued at approximately $3,700,514.16. This trade represents a 1.26 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO David Lunin purchased 2,500 shares of the business's stock in a transaction that occurred on Tuesday, March 4th. The stock was bought at an average price of $13.05 per share, for a total transaction of $32,625.00. Following the purchase, the chief financial officer now directly owns 2,500 shares in the company, valued at $32,625. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. 2.91% of the stock is owned by corporate insiders.

About Calumet Specialty Products Partners

(Get Free Report)

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

Further Reading

Should You Invest $1,000 in Calumet Specialty Products Partners Right Now?

Before you consider Calumet Specialty Products Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.

While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!

While tech giants are down, "boring" bank stocks are quietly outperforming. Find out how to leverage these banks' stability for significant gains!

Related Videos

Why Palantir’s Future Just Got a Massive Boost
7 Flying Car Stocks to Buy Before the Sector Really Takes Off
Archer Aviation: Sinking Now, Soaring Soon?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads